Cargando…
The Good the Bad and the Ugly of Glycosaminoglycans in Tissue Engineering Applications
High sulfation, low cost, and the status of heparin as an already FDA- and EMA- approved product, mean that its inclusion in tissue engineering (TE) strategies is becoming increasingly popular. However, the use of heparin may represent a naïve approach. This is because tissue formation is a highly o...
Autores principales: | Ayerst, Bethanie I., Merry, Catherine L.R., Day, Anthony J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5490411/ https://www.ncbi.nlm.nih.gov/pubmed/28608822 http://dx.doi.org/10.3390/ph10020054 |
Ejemplares similares
-
Pterygium—The Good, the Bad, and the Ugly
por: Van Acker, Sara I., et al.
Publicado: (2021) -
“The Good, the Bad and the Ugly” of Chitosans
por: Bellich, Barbara, et al.
Publicado: (2016) -
Hydroxyurea—The Good, the Bad and the Ugly
por: Musiałek, Marcelina W., et al.
Publicado: (2021) -
Growth Differentiation Factor 5-Mediated Enhancement of Chondrocyte Phenotype Is Inhibited by Heparin: Implications for the Use of Heparin in the Clinic and in Tissue Engineering Applications
por: Ayerst, Bethanie I., et al.
Publicado: (2017) -
Renal Angiomyolipoma: The Good, the Bad, and the Ugly
por: Vos, Nicolas, et al.
Publicado: (2018)